A Qualitative Study of Patients, Caregivers, and Providers on Barriers to Kidney Re-Transplantation Following Graft Loss

Background: Many kidney transplant recipients experience graft loss, and re-transplantation offers a significant survival benefit when compared with waitlisted patients. Yet trends related to pre-emptive re-listing/re-transplantation are sub-optimal. Little empirical evidence has explored barriers to kidney re-transplantation. We aimed to identify the predominant barriers to re-transplantation after graft loss and factors that hinder the pursuit of living kidney donor (LKD) re-transplantation. Methods: This was a qualitative study that used an interpretive descriptive design. Participants included patients with a history of graft loss, caregivers who supported them, and transplant nephrologists, recruited using purposive and snowball sampling techniques. Data collection entailed semi-structured interviews that were coded, and an inductive thematic analysis was conducted. Results: We synthesized the perspectives of 23 patients, 23 caregivers, and 11 transplant nephrologists representing 11 Canadian transplant programs. Through our analysis, we identified four key barriers to re-transplantation: high antibody sensitization resulting in scarcity of compatible donors; prevalence of comorbidities leading to ineligibility or wait list withdrawal; history of non-adherence among the recipients leading to ineligibility or delays in transplant referral and re-evaluation; and delayed referrals and poor coordination of re-transplant workup. Additional barriers to LKD re-transplantation included patient preference for deceased donor transplantation that was unlikely to change after graft loss; perceived smaller pool of eligible LKDs felt to have been exhausted with the first transplant; the psychological burden of unresolved issues related to prior LKD transplant loss; and overall structural barriers to living kidney donation. Conclusions: This analysis highlights both medical and non-medical barriers to re-transplantation and that the pursuit of re-transplantation entails persistent as well as additional and compounding challenges. A list of implications that arise from these findings is presented. Given the well-established benefits of kidney transplantation and that graft loss remains a leading cause of dialysis initiation, these findings have important implications for the nephrology community.

Authors

Institutions

Publication Details

Journal
Clinical Journal of the American Society of Nephrology
Published
2026-07-22
DOI
https://doi.org/10.2215/cjn.0000001162
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Qualitative Study of Patients, Caregivers, and Providers on Barriers to Kidney Re-Transplantation Following Graft Loss

Mathilde Gouin-Bonenfant, Anita Slominska, Ngan N. Lam, Shaifali Sandal et al.
Clinical Journal of the American Society of Nephrology
Renal Transplantation Outcomes and Treatments
article

A Qualitative Study of Patients, Caregivers, and Providers on Barriers to Kidney Re-Transplantation Following Graft Loss

Mathilde Gouin-Bonenfant, Anita Slominska, Ngan N. Lam, Shaifali Sandal, M. Khaled Shamseddin, Ann Bugeja, Marie‐Chantal Fortin, Saly El Wazze, Marcelo Cantarovich, Elizabeth Anne Kinsella, Julie Ho, Emma Katz, Kathleen Gaudio, Tal Sterling-Eilok
article en

Abstract

Background: Many kidney transplant recipients experience graft loss, and re-transplantation offers a significant survival benefit when compared with waitlisted patients. Yet trends related to pre-emptive re-listing/re-transplantation are sub-optimal. Little empirical evidence has explored barriers to kidney re-transplantation. We aimed to identify the predominant barriers to re-transplantation after graft loss and factors that hinder the pursuit of living kidney donor (LKD) re-transplantation. Methods: This was a qualitative study that used an interpretive descriptive design. Participants included patients with a history of graft loss, caregivers who supported them, and transplant nephrologists, recruited using purposive and snowball sampling techniques. Data collection entailed semi-structured interviews that were coded, and an inductive thematic analysis was conducted. Results: We synthesized the perspectives of 23 patients, 23 caregivers, and 11 transplant nephrologists representing 11 Canadian transplant programs. Through our analysis, we identified four key barriers to re-transplantation: high antibody sensitization resulting in scarcity of compatible donors; prevalence of comorbidities leading to ineligibility or wait list withdrawal; history of non-adherence among the recipients leading to ineligibility or delays in transplant referral and re-evaluation; and delayed referrals and poor coordination of re-transplant workup. Additional barriers to LKD re-transplantation included patient preference for deceased donor transplantation that was unlikely to change after graft loss; perceived smaller pool of eligible LKDs felt to have been exhausted with the first transplant; the psychological burden of unresolved issues related to prior LKD transplant loss; and overall structural barriers to living kidney donation. Conclusions: This analysis highlights both medical and non-medical barriers to re-transplantation and that the pursuit of re-transplantation entails persistent as well as additional and compounding challenges. A list of implications that arise from these findings is presented. Given the well-established benefits of kidney transplantation and that graft loss remains a leading cause of dialysis initiation, these findings have important implications for the nephrology community.

Clinical Journal of the American Society of Nephrology
University of Ottawa (CA), University of Calgary (CA), Queen's University (CA), Ottawa Hospital (CA), McGill University Health Centre (CA), Centre Hospitalier de l’Université de Montréal (CA), University of Manitoba (CA), McGill University (CA)
No poverty
Openalex Percentile: Top 6%
Renal Transplantation Outcomes and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.